Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Coastal Financial Corporation's subsidiary, Coastal Community Bank, provided an update regarding its fintech partner Dave Inc., which has applied for a national bank charter with the OCC. The company clarified that existing agreements remain in place, including a recently expanded $325 million capacity for Dave's ExtraCash product, and does not expect the potential charter to have a material adverse effect on its financial condition.
CDT Equity Inc. stockholders approved a proposal to authorize the board of directors to effect a reverse stock split at a ratio ranging from 1-for-2 to 1-for-100. Stockholders also approved the issuance of common stock under Nasdaq Listing Rule 5635 related to convertible notes and warrants issued to J.J. Astor & Co.
Zach Davis has been appointed as President and Chief Financial Officer of Cheniere Partners GP, LLC, the general partner of Cheniere Energy Partners, L.P., effective November 16, 2026. Mr. Davis, who has served as CFO since 2020, expands his role while Jack Fusco continues as Chairman and CEO. This appointment aligns the leadership structure with parent company Cheniere Energy, Inc., where Mr. Davis also serves as President and CFO.
Bally's Corp reported Q3 2026 consolidated revenue of $807.6 million, a 21.7% increase year-over-year, driven by strong growth in its Intralot B2C and North America Interactive segments. The company also highlighted the closing of a $400 million term loan for its Bronx project and confirmed that construction of its permanent Chicago casino remains on schedule for a spring 2027 opening.
“We delivered another solid quarter, with consolidated revenue up 21.7% year over year. Revenue growth was led by Bally’s Intralot B2C which rose 22.8% and North America Interactive which increased 25.6% while Casinos & Resorts revenue rose 3.2% reflecting strong regional gaming performance.”
Robeson Reeves, Bally’s Chief Executive Officer
“Bally’s will meet and likely exceed the $1.34 billion minimum capital commitment required under our agreement with the City of Chicago, we have the capital resources necessary to do so and are very excited to bring Chicago its first and only full service gaming and entertainment resort.”
VenHub Global, Inc. reported a net loss of $38.1 million for the nine months ended September 30, 2026, compared to a $49.2 million loss in the prior year period. Total revenue decreased to $244,245 from $808,972 year-over-year, primarily due to the absence of store sales, while the company continues to manage significant operating expenses and a stockholders' deficit of $5.0 million.
Teamshares Inc. reported total revenue of $417.6 million for the nine months ended September 30, 2026, a 21% increase year-over-year, though it recorded a net loss of $22.6 million. The company significantly strengthened its balance sheet through a merger and PIPE financing, as well as the issuance of $225 million in perpetual non-convertible preferred stock.
Stem, Inc. reported total revenue of $36.7 million for the third quarter of 2026, a slight decrease from $38.2 million in the prior year period. The company saw a significant reduction in net loss to $14.6 million compared to a $23.8 million loss in Q3 2025, driven by improved gross margins and lower operating expenses.
Flash Sports & Media Holdings, Inc. completed a pivot from agriculture to sports and media following a merger, resulting in a significant increase in total assets to $256.5 million. Despite generating $8.17 million in revenue for the nine months ended September 30, 2026, the company reported a net loss of $19.4 million and expressed substantial doubt about its ability to continue as a going concern.
Dawson Geophysical reported a net loss of $946,000 for the nine months ended September 30, 2026, an improvement from the $2,510,000 loss in the prior year period. Total operating revenues increased significantly to $66,029,000 from $48,675,000, driven by higher fee revenue, though the company experienced a substantial net loss of $5,167,000 in the third quarter of 2026.
AEON Biopharma reported a net loss of $10.5 million for the nine months ended September 30, 2026, compared to a $2.1 million loss in the prior year period. The company significantly strengthened its balance sheet through public offerings and PIPE financing, increasing cash and cash equivalents to $11.4 million and reducing total liabilities from $60.6 million to $11.7 million.
For the nine months ended September 30, 2026, ORIC Pharmaceuticals reported a net loss of $125.3 million, an increase from the $99.0 million loss in the prior year period, primarily driven by higher research and development expenses. As of September 30, 2026, the company maintained a strong liquidity position with $345.4 million in cash, cash equivalents, and investments.
Twist Bioscience reported net proceeds of approximately $327.7 million from an August 2026 public offering and $97.1 million from an at-the-market program. Despite these capital raises, the company anticipates continued net losses and negative free cash flows for the near future while expanding international operations, which accounted for 41% of revenue in fiscal 2026.
Keurig Dr Pepper completed a public offering of 66,666,667 shares of common stock (including the full exercise of the underwriters' option) at a price of $34.50 per share. The company received approximately $2.25 billion in net proceeds, which it intends to use to repay outstanding debt and accelerate deleveraging. This financial move is intended to optimize the balance sheet ahead of the company's planned separation into two independent public companies in early 2027.
American Tower $1.33B Debt Financing with Morgan Stanley & Co. International plc
American Tower Corporation priced a registered public offering of senior unsecured notes in two tranches: €600 million due 2031 at 4.200% and €600 million due 2034 at 4.500%. The total aggregate principal amount is approximately $1.33 billion USD, with net proceeds intended for general corporate purposes and refinancing upcoming euro-denominated debt maturities.
Patrick Industries announced that its Board of Directors authorized a replenishment of its share repurchase program to $200 million and increased its quarterly cash dividend by 11% to $0.52 per share. While the buyback was authorized, the company noted it is currently restricted from repurchasing shares due to operating covenants in its pending all-stock merger agreement with LCI Industries.
Peoples Financial Services Corp. filed its Q3 2026 investor presentation to be used in upcoming meetings with investors. The presentation provides a strategic and financial overview of the company and its subsidiary, Peoples Security Bank and Trust Company.
Harrow, Inc. filed a formal corporate presentation to be used by management at the Jefferies Global Healthcare Conference in London. The presentation highlights the company's ophthalmic pharmaceutical portfolio, including core growth brands VEVYE, IHEEZO, and TRIESENCE. The filing is a standard Regulation FD disclosure to provide the investment community with updated strategic and commercial information.
T Stamp Inc. (Trust Stamp) reported financial results for the nine months ended September 30, 2026, featuring a 28% increase in net revenue to $2.85 million. The company noted that revenue growth is significantly outpacing the growth in cash expenses, driven by work with an S&P 500 bank and a multinational telecommunications corporation. Trust Stamp also highlighted a maturing revenue pipeline with a conservative FY 2027 projection of $8.17 million in booked revenue.
Pool Corporation (POOL) has signed a definitive agreement to acquire Team Horner Group, Inc., a Florida-based wholesale distributor of swimming pool products. The acquisition includes 18 sales centers and manufacturing operations for pool heat pumps and salt chlorine generators. The deal is expected to close in Q1 2027 and will be funded through POOL's revolving credit facility and cash on hand.
Vulcan Infrastructure and Power reported Q3 2026 financial results, highlighting a strategic transition toward AI and high-performance computing (HPC) infrastructure. The company strengthened its balance sheet by completing a $39.3 million strategic investment and redeeming its 2026 Senior Notes, effectively eliminating its 2026 debt maturity.
“During the third quarter and subsequent to quarter-end, we completed three important steps in Vulcan’s transition. In September, we closed a $39.3 million strategic investment from Atlas Holdings, Machine Investment Group, Conversant Capital, and other investors, and in October we completed the full redemption of our 8.50% Senior Notes due 2026 (the “2026 Notes”).”
Jordan Kovler, CEO
“Our immediate focus is on advancing our owned sites at Dresden and Columbus through predevelopment work and with AI/HPC customers. Our objective is to translate the power and infrastructure value of these assets into contracted, predictable, long-duration cash flows.”
ORIC Pharmaceuticals reported third quarter 2026 financial results and provided updates on its late-stage oncology portfolio, including the initiation of the Himalayas-1 Phase 3 trial for rinzimetostat in prostate cancer. The company ended the quarter with $345 million in cash and investments, which is expected to fund operations into the second half of 2028.
“Recent clinical data updates reinforce our confidence in the best-in-class potential of our late-stage portfolio, with rinzimetostat continuing to demonstrate an efficacy and safety profile in prostate cancer that is differentiated from current standards of care and the only other PRC2 inhibitor in Phase 3 development, and with enozertinib setting a new benchmark in 1L EGFR atypical NSCLC.”
Jacob M. Chacko, M.D., president and chief executive officer
“With the first Phase 3 trials either underway or planned across both programs and supported by a strong balance sheet, we are laser focused on execution in pursuit of our mission to Overcome Resistance In Cancer.”
Jacob M. Chacko, M.D., president and chief executive officer
Enanta Pharmaceuticals reported fiscal fourth quarter 2026 revenue of $12.9 million and a net loss of $28.3 million, driven by royalty revenue from AbbVie's HCV regimen. The company highlighted clinical progress in its RSV and immunology pipelines, including the completion of enrollment for its Phase 2b LOTUS trial. Enanta also announced the planned retirement of CEO Jay R. Luly by February 2027.
Counterparty
AbbVie
“During fiscal 2026 we made significant progress across our virology and immunology portfolios. In RSV, we completed enrollment in LOTUS, a Phase 2b trial of zelicapavir in pediatric patients, with topline data expected in the first quarter of 2027. We also began dosing patients in RESOLVE, a Phase 2b/3 trial of zelicapavir in adults at high risk of severe disease and anticipate reporting data from the Phase 2b portion in 2027.”
Jay R. Luly, Ph.D., President and Chief Executive Officer
“In parallel, we are advancing a growing immunology portfolio focused on developing best-in-class oral medicines that have the potential to raise the standard of care across multiple immune-mediated diseases. We expect to complete dosing in the EDP-978 Phase 1 trial by year-end 2026 and now plan to report data in the first quarter of 2027.”
Jay R. Luly, Ph.D., President and Chief Executive Officer
Omeros Corporation reported Q3 2026 financial results, highlighted by a 26% sequential increase in net revenue for YARTEMLEA to $35.9 million. The company reported a GAAP net loss of $57.4 million, primarily driven by a $62.0 million non-cash mark-to-market adjustment on convertible notes, while achieving positive operating cash flow of $13.3 million.
Term
Q3 2026
“YARTEMLEA sales continued to grow during the third quarter, delivering consecutive quarters of positive operating cash flow. As expected, 340B participation increased, reflecting substantial expansion of our customer base and increased outpatient use of YARTEMLEA. That momentum has continued into the fourth quarter, with YARTEMLEA revenues continuing to grow.”
Gregory A. Demopulos, M.D., Omeros’ Chairman and Chief Executive Officer
Lifeloc Technologies reported Q3 2026 net revenue of $2.522 million, a 12% increase year-over-year, and a narrowed net loss of $85 thousand. The company highlighted margin improvements from price increases and continued heavy R&D investment in its SpinDetect drug analyzer platform, which is entering beta testing.
Getty Images reported Q3 2026 revenue of $234.0 million, a 2.5% year-over-year decrease, and a net loss of $564.5 million primarily driven by $563.2 million in non-cash impairment charges. The company also announced it has initiated a prepackaged Chapter 11 restructuring process to transition to a privately held company with the support of the Getty family and Koch Equity Development.
Term
Q3 2026
“As recently announced, we initiated a financial restructuring to significantly strengthen our financial foundation and accelerate our ability to invest for growth with the support of the Getty family, Koch Equity Development and our lenders as a privately held company.”
Craig Peters, Chief Executive Officer of Getty Images
“We continue to service our customers through the world's best authentic visual content and coverage. Importantly, we remain focused on what we do best, which is helping our customers engage their audiences.”
Craig Peters, Chief Executive Officer of Getty Images
Carpenter Technology Corporation promoted Marshall D. Akins to Senior Vice President – Chief Operating Officer, effective immediately. The company also announced the promotions of John Huyette to Vice President – Chief Commercial Officer and Bill Besash to Vice President – Investor Relations and Corporate Development. Mr. Akins will receive a base salary of $580,000 and an annual equity incentive award valued at $1.3 million.
Luvu Brands reported first quarter fiscal 2027 net sales growth of 10% to $6.8 million, driven by strength in wholesale and international channels. Despite the revenue growth, the company reported a net loss of $365,000 as higher freight and manufacturing labor costs compressed gross margins to 26.2%.
Term
Q1 2027
“We opened fiscal 2027 with double-digit top-line growth, led by continued strength in our Wholesale channel, particularly adult retailers and international customers, and by better conversion on our Liberator website following its move to the Shopify platform. We are adding distribution points at home and abroad, and we are encouraged by the momentum in both our Direct and Wholesale channels.”
Louis Friedman, Founder, Chief Executive Officer of Luvu Brands
Roadzen reported record quarterly revenue of $17.6 million for Q2 fiscal 2027, representing 28.6% year-over-year growth. The company achieved its first-ever positive Adjusted EBITDA quarter and narrowed its operating loss by 24% as it targets a $100 million annualized revenue run rate by fiscal year-end.
Term
Q2 2027
“This is the quarter we have been building toward for two years. Roadzen generated positive Adjusted EBITDA for the first time in its history, on record revenue of $17.6 million, our third record quarter in a row, after nine consecutive quarters of disciplined improvement.”
Rohan Malhotra, Founder and CEO of Roadzen
“We process more than three million claims a year, our driver-safety AI runs across billions of miles of real-world driving, and our AI agents now do work inside inspection, claims and repair that used to take weeks, and that is the engine behind these numbers.”
Roadzen reported record revenue of $17.6 million for the second fiscal quarter, up 28.6% year-over-year, and achieved its first positive Adjusted EBITDA quarter in company history. The company also announced a $10 million equity financing for its India subsidiary at a $300 million post-money valuation and reaffirmed its target to exit fiscal 2027 at a $100 million-plus annualized revenue run rate.
Term
Q2 2027
“This is the quarter we have been building toward for two years. Roadzen generated positive Adjusted EBITDA for the first time in its history, on record revenue of $17.6 million, our third record quarter in a row, after nine consecutive quarters of disciplined improvement.”
Rohan Malhotra, Founder and CEO of Roadzen
“We process more than three million claims a year, our driver-safety AI runs across billions of miles of real-world driving, and our AI agents now do work inside inspection, claims and repair that used to take weeks, and that is the engine behind these numbers.”
Infleqtion reported record Q3 2026 revenue of $9.1 million, a 25% year-over-year increase, driven by its neutral atom quantum computing and sensing business. The company achieved a major technical milestone by demonstrating 30 logical qubits and maintained its full-year 2026 revenue guidance of at least $45.1 million.
Term
Q3 2026
“We are building Infleqtion to lead in utility-scale quantum computing, and this quarter’s progress strengthens our confidence in that ambition. Delivering 30 logical qubits is an important step on our technology roadmap. Alongside that progress, growth in our backlog and remaining performance obligations gives us confidence in a strong 2027 across computing and sensing, with computing becoming a meaningfully larger part of our business.”